top glp 1 drugs List of approved and pending GLP-1 medications The GLP-1 Agonists and Obesity:
Description
Clinical relevance of anti-exenatide antibodies: safety, efficacy and cross-reactivity with long-term treatment
Nausea and vomiting associated with GLP-1 agonists The majority of people who start using a GLP-1 for obesity will discontinue it in the first year, with 45% to 65% citing GI side effects as the reason for discontinuing therapy
BMI does not distinguish between muscle mass and fat mass
Schwartz MW, Figlewicz DF, Kahn SE, Baskin DG, Greenwood MR, Porte D, Jr
Check your formulary tier : Lower tiers mean a lower copay
